AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease

Gastroenterology

Volumn 138, Issue 2, 2010, Pages

  Farraye, Francis A ^a   Odze, Robert D ^b   Eaden, Jayne ^c   Itzkowitz, Steven H ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOSALICYLIC ACID DERIVATIVE; AZATHIOPRINE; BALSALAZIDE; CALCIUM; CORTICOSTEROID; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOMODULATING AGENT; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; MOLECULAR MARKER; MULTIVITAMIN; OLSALAZINE; PREDNISONE; SALAZOSULFAPYRIDINE; URSODEOXYCHOLIC ACID;

ARTICLE; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC IMAGING; DISEASE COURSE; DYSPLASIA; ENTERITIS; HUMAN; MEDICAL SOCIETY; PRIORITY JOURNAL;

EID: 75149167913     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.12.035     Document Type: Article

References (50)

1. Crohn B., and Rosenberg H. The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Am J Med Sci 170 (1925) 220-228
2. Warren S., and Sommers S. Cicatrizing enteritis as a pathological entity. Am J Pathol 24 (1948) 475-501
3. Eaden J.A., Abrams K.R., and Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48 (2001) 526-535
4. Hendriksen C., Kreiner S., and Binder V. Long term prognosis in ulcerative colitis-based on results from a regional patient group from the county of Copenhagen. Gut 26 (1985) 158-163
5. Greenstein A.J., Sachar D.B., Smith H., et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 77 (1979) 290-294
6. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 130 (2006) 1030-1038
7. Jess T., Loftus Jr. E.V., Velayos F.S., et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Oolmsted Ccounty, Minnesota. Gastroenterology 130 (2006) 1039-1046
8. Loftus Jr. E.V. Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis. Gastroenterol Clin North Am 35 (2006) 517-531
9. Weedon D.D., Shorter R.G., Ilstrup D.M., et al. Crohn's disease and cancer. N Engl J Med 289 (1973) 1099-1103
10. Munkholm P., Langholz E., Davidsen M., et al. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 105 (1993) 1716-1723
11. Ekbom A., Helmick C., Zack M., et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 336 (1990) 357-359
12. Jess T., Winther K.V., Munkholm P., et al. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther 19 (2004) 287-293
13. Eaden J., Abrams K., Ekbom A., et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 14 (2000) 145-153
14. Moody G.A., Jayanthi V., Probert C.S., et al. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 8 (1996) 1179-1183
15. Pinczowski D., Ekbom A., Baron J., et al. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 107 (1994) 117-120
16. Jess T., Gamborg M., Matzen P., et al. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 100 (2005) 2724-2729
17. Canavan C., Abrams K.R., and Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 23 (2006) 1097-1104
18. Bernstein C.N., Blanchard J.F., Kliewer E., et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91 (2001) 854-862
19. Gillen C.D., Walmsley R.S., Prior P., et al. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 35 (1994) 1590-1592
20. Choi P.M., and Zelig M.P. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 35 (1994) 950-954
21. Lutgens M.W., Vleggaar F.P., Schipper M.E., et al. High frequency of early colorectal cancer in inflammatory bowel disease. Gut 57 (2008) 1246-1251
22. Gillen C.D., Andrews H.A., Prior P., et al. Crohn's disease and colorectal cancer. Gut 35 (1994) 651-655
23. Gyde S.N., Prior P., Allan R.N., et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 29 (1988) 206-217
24. Ekbom A., Helmick C., Zack M., et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323 (1990) 1228-1233
25. Sugita A., Sachar D.B., Bodian C., et al. Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut 32 (1991) 167-169
26. Heuschen U.A., Hinz U., Allemeyer E.H., et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology 120 (2001) 841-847
27. Haskell H., Andrews Jr. C.W., Reddy S.I., et al. Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis. Am J Surg Pathol 29 (2005) 1472-1481
28. Broome U., Lofberg R., Veress B., et al. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 22 (1995) 1404-1408
29. Aitola P., Mattila J., and Matikainen M. Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma. Int J Colorectal Dis 15 (2000) 167-171
30. Brentnall T.A., Haggitt R.C., Rabinovitch P.S., et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 110 (1996) 331-338
31. D'Haens G.R., Lashner B.A., and Hanauer S.B. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol 88 (1993) 1174-1178
32. Kornfeld D., Ekbom A., and Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis?. A population based study. Gut 41 (1997) 522-525
33. Marchesa P., Lashner B.A., Lavery I.C., et al. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 92 (1997) 1285-1288
34. Shetty K., Rybicki L., Brzezinski A., et al. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 94 (1999) 1643-1649
35. Loftus Jr. E.V., Sandborn W.J., Tremaine W.J., et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 110 (1996) 432-440
36. Nuako K.W., Ahlquist D.A., Sandborn W.J., et al. Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis: a case-control study. Cancer 82 (1998) 822-826
37. Soetikno R.M., Lin O.S., Heidenreich P.A., et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 56 (2002) 48-54
38. Higashi H., Yanaga K., Marsh J.W., et al. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 11 (1990) 477-480
39. Bleday R., Lee E., Jessurun J., et al. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 36 (1993) 908-912
40. Loftus Jr. E.V., Aguilar H.I., Sandborn W.J., et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 27 (1998) 685-690
41. Vera A., Gunson B.K., Ussatoff V., et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation 75 (2003) 1983-1988
42. Nuako K.W., Ahlquist D.A., Mahoney D.W., et al. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology 115 (1998) 1079-1083
43. Askling J., Dickman P.W., Karlen P., et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 120 (2001) 1356-1362
44. Askling J., Dickman P.W., Karlen P., et al. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet 357 (2001) 262-266
45. Devroede G.J., Taylor W.F., Sauer W.G., et al. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 285 (1971) 17-21
46. Markowitz J., McKinley M., Kahn E., et al. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis. Am J Gastroenterol 92 (1997) 2001-2006
47. Friedman S., Rubin P.H., Bodian C., et al. Screening and surveillance colonoscopy in chronic Crohn's colitis. Gastroenterology 120 (2001) 820-826
48. Rutter M., Saunders B., Wilkinson K., et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126 2 (2004) 451-459
49. Gupta R.B., Harpaz N., Itzkowitz S., et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 133 (2007) 1099-1105 quiz 1340-1341
50. Rubin D., Huo D., Rothe J., et al. Increased inflammatory activity is an independent risk factor for dysplasia and colorectal cancer in ulcerative colitis: a case-control analysis with blinded prospective review of pathology. Gastroenterology 130 Suppl 2 (2006) A2